ArticleCase reports in oncology

Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report.

Nora Asper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.